The chemists of the “Metal complexes and MRI” research group have developed novel imaging probes which specifically recognise amyloid aggregates, characteristic of Alzheimer’s Disease and Diabetes and gained new insights into their peptide binding mechanisms. These results could facilitate early diagnosis and better molecular understanding of these diseases.
A lire aussi
2024 May, 7 - El Hadji Cisse Defensis
23 April 2024
par Isabelle Frapart
July 1st-3rd "Skin Models in Cosmetic Science: Bridging Established Methods and Novel Technologies" - 3rd meeting
23 April 2024
par Isabelle Frapart
2024, May 24 - Seminar of Frank Schreiber
16 April 2024
par Isabelle Frapart